Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 07, 2018 5:30pm EDT
Biotech Industry Veteran Dietmar Berger, M.D., Ph.D., Joins Atara Biotherapeutics as Global Head of Research and Development May 07, 2018 8:00am EDT
Atara Biotherapeutics Expands Commercial Leadership Team with the Appointment of Manuela Maronati as General Manager, Europe May 01, 2018 8:00am EDT
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Apr 09, 2018 4:45pm EDT
Atara Biotherapeutics to Participate in Three Upcoming Immuno-Oncology Conferences Mar 22, 2018 4:30pm EDT
Atara Biotherapeutics to Present at the 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) Mar 16, 2018 8:00am EDT
Atara Biotherapeutics to Present at the Cowen and Company 38th Annual Health Care Conference Mar 06, 2018 4:05pm EST
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Progress Feb 27, 2018 7:00am EST
